News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
323 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (4152)
February (4569)
March (4908)
April (4902)
May (5255)
June (4735)
July (4593)
August (4725)
September (5112)
October (5032)
November (5368)
December (4315)
Day
1 (2)
2 (8)
3 (239)
4 (237)
5 (215)
6 (254)
7 (91)
8 (4)
9 (4)
10 (258)
11 (248)
12 (223)
13 (237)
14 (120)
15 (9)
17 (67)
18 (307)
19 (282)
20 (283)
21 (121)
22 (2)
23 (8)
24 (291)
25 (323)
26 (288)
27 (305)
28 (141)
29 (2)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
17
18
19
20
21
22
23
24
25
26
27
28
29
Polyphor announces progress of the Phase III immuno-oncology program with balixafortide. Renewed strategy in advancing antibiotics and oncology research and pipeline
Polyphor AG, a research based clinical stage biopharmaceutical company, announces progress of the Phase III immuno-oncology program with balixafortide and a renewed strategy in advancing antibiotics and oncology research and pipeline.
February 25, 2020
·
7 min read
BioMidwest
Osteosarcoma profiling reveals why immunotherapy remains ineffective
Study points to strategies for improving outcomes with immunotherapy in rare cancer type
February 25, 2020
·
5 min read
BioMidwest
Recipharm names 2019 International Environmental Award winner
Recipharm has announced its 2019 International Environmental Award will be presented to Dana Kolpin, Research Hydrologist at the U.S. Geological Survey Central Midwest Water Science Center in Iowa City, Iowa.
February 25, 2020
·
4 min read
Genetown
Moderna’s Coronavirus Vaccine Ready for Clinical Trials
As the number of cases and deaths continues to increase in China and around the world, Moderna shipped its first batch of mRNA-1273, a vaccine against the virus, for a planned Phase I clinical trial in the U.S.
February 25, 2020
·
3 min read
·
Mark Terry
Policy
FDA Accepts GSK’s sNDA for Zejula as a First-Line Maintenance Treatment in Ovarian Cancer
The FDA is reviewing the sNDA under the Real-Time Oncology Review (RTOR) pilot program, which could speed up the process for potential approval.
February 25, 2020
·
2 min read
·
Alex Keown
Business
Bicycle and Genentech Forge Immuno-Oncology Collaboration Worth up to $1.7 Billion
In its announcement, Bicycle did not identify the cancer targets it will focus on in its collaboration with Genentech.
February 25, 2020
·
2 min read
·
Alex Keown
Pharm Country
Life Science Instrumentation Market: Spectroscopy Segment to Lead Global Market
Analytical science has built up itself valuable in breaking down the arrangement of materials and it is being utilized in several applications.
February 25, 2020
·
5 min read
Pharm Country
Ophthalmology Surgical Devices Market: Rising Incidence of Eye Disorders to Propel Demand, TMR
The global ophthalmology surgical devices market was valued at around US$ 7.0 Bn in 2016 and is expected to expand at a CAGR of over 4.0% from 2017 to 2025, to reach value of around US$ 11.0 Bn by 2025.
February 25, 2020
·
5 min read
Biotech Bay
Digital Health Market – Untapped Industry Opportunities Analysis Report
The global digital health market is driven by a rising demand for improved communication between healthcare professionals and patients so as to reduce medication errors and provide improved coordinated care.
February 25, 2020
·
5 min read
Deals
4basebio AG announces allotment ratio and final number of shares for the share buy back
4basebio AG announces the allotment ratio and the final number of shares for the announced share buyback program.
February 25, 2020
·
3 min read
1 of 33
Next